The "TBX5 Full-Length Gene Sequence Analysis Holt-Oram Syndrome Test" is a specialized genetic test available at DNA Labs UAE, designed to identify mutations in the TBX5 gene, which are closely associated with Holt-Oram Syndrome (HOS). HOS is a genetic condition characterized by skeletal abnormalities of the hands and arms (upper limbs) and heart defects. The TBX5 gene plays a critical role in the development of the heart and upper limbs during embryogenesis, and mutations in this gene can lead to the characteristic features of Holt-Oram Syndrome.
This comprehensive test involves sequencing the full length of the TBX5 gene to detect any genetic alterations that might be responsible for the condition. By identifying specific mutations, the test can confirm a diagnosis of Holt-Oram Syndrome, which is crucial for the management and treatment of the disorder. It can also provide important information for family planning and genetic counseling for affected families.
The cost of the test is 7500 AED, reflecting the intricate technology and expertise required to accurately sequence and analyze the gene. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, this test represents a significant step forward in the personalized diagnosis and understanding of genetic disorders like Holt-Oram Syndrome.
Clinical Exome Sequencing for Couples is a comprehensive genetic test offered by DNA Labs UAE, designed to analyze the exomes - the parts of the genome that code for proteins, which constitute about 1-2% of the human genome but contain about 85% of known genetic disease causes. This test is particularly valuable for couples who are planning to start a family and wish to understand their risk of passing on genetic disorders to their offspring.
The process involves collecting DNA samples from both partners, usually through a simple blood draw. The samples are then sequenced to identify any genetic variations that could potentially lead to health issues in their children. By examining the exomes of both parents, the test can provide insights into a wide range of inherited conditions, enabling couples to make informed decisions about their reproductive options.
The test is priced at 7500 AED, reflecting the extensive analysis and personalized consultation that accompanies the results. DNA Labs UAE, known for its cutting-edge genetic testing services, employs state-of-the-art technology and adheres to strict confidentiality and ethical standards, ensuring that couples receive accurate, useful, and private genetic counseling based on their test results. This service is an investment in the health and well-being of future generations, offering peace of mind and empowering couples with critical information about their genetic health.
The Oncomine Comprehensive Myeloid Panel Test is a cutting-edge diagnostic tool designed to provide a comprehensive genetic analysis of myeloid cancers. This innovative test, available at DNA Labs UAE, leverages next-generation sequencing technology to examine a wide array of genetic mutations associated with various myeloid malignancies, including leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. By analyzing the genetic blueprint of a patient's cancer, the Oncomine Comprehensive Myeloid Panel Test helps healthcare professionals to tailor personalized treatment plans, predict disease progression, and identify potential therapeutic targets.
Priced at 6400 AED, this test represents a significant investment in the precision and personalization of cancer care. Despite the cost, the value derived from the detailed insights into the genetic underpinnings of an individual's cancer can be pivotal in guiding treatment decisions, potentially improving outcomes and quality of life for patients with myeloid malignancies. DNA Labs UAE, a reputable facility known for its advanced diagnostic services, ensures that the Oncomine Comprehensive Myeloid Panel Test is conducted with the highest standards of accuracy and reliability, offering patients and healthcare providers a crucial tool in the fight against myeloid cancers.
The "Arthrogryposis and Congenital Myasthenic Syndrome Gene Panel Test" is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to identify genetic mutations associated with Arthrogryposis and Congenital Myasthenic Syndrome (CMS). Arthrogryposis refers to a range of conditions characterized by joint contractures and muscle weakness present at birth, while CMS encompasses a group of genetic disorders that result in muscle fatigue and weakness due to impaired transmission of signals between nerves and muscles.
This gene panel test targets specific genes known to be linked to these conditions, facilitating an accurate diagnosis and enabling healthcare providers to tailor treatment plans effectively. Given the genetic complexity and variability of these disorders, the panel approach increases the likelihood of identifying the underlying genetic cause.
Priced at 8890 AED, the test represents a significant investment in pinpointing the genetic underpinnings of these conditions, offering hope for affected individuals and their families for better management and understanding of their health challenges. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, patients can expect a high level of accuracy and reliability in the test results, paving the way for improved outcomes.
The Ataxia Gene Panel Test, available at DNA Labs UAE for 7200 AED, is a comprehensive diagnostic tool designed to identify genetic mutations associated with various forms of ataxia. Ataxia, a neurological condition characterized by impaired balance, coordination, and speech, can be caused by mutations in multiple genes. This panel test examines a broad spectrum of genes simultaneously to pinpoint the specific genetic alterations responsible for the condition in an individual.
By leveraging advanced genetic sequencing technologies, the test offers a precise and efficient approach to diagnosing different types of hereditary ataxias. This is particularly valuable for individuals exhibiting ataxia symptoms, families with a history of the condition, or those seeking a definitive genetic explanation for neurological symptoms of unknown cause. The information obtained from the test can guide clinical management, inform prognosis, and assist in family planning decisions.
Conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services, clients are assured of accurate and reliable results. The cost of the test is set at 7200 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology employed.
The Benign Infantile Epilepsy Gene Panel Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify specific genetic mutations associated with benign infantile epilepsy (BIE). This condition, typically emerging in the early months of a child's life, is characterized by seizures that the child eventually outgrows, usually without long-term neurological effects. However, early and accurate diagnosis is crucial for effective management and to differentiate BIE from other more serious neurological conditions.
The test involves analyzing a small sample of the patient's DNA, extracted from a blood sample, to scrutinize multiple genes known to be linked with benign infantile epilepsy. By employing cutting-edge genetic sequencing technologies, DNA Labs UAE ensures a comprehensive examination of these genes, facilitating a precise diagnosis.
The cost of the Benign Infantile Epilepsy Gene Panel Test at DNA Labs UAE is 7200 AED. This price reflects the advanced technology and expertise required to perform this intricate analysis. For families and physicians, the test offers invaluable insights, enabling tailored treatment plans that can significantly improve the quality of life for affected infants, ensuring they receive the most appropriate care from the earliest stages of their lives.
Bone Marrow Failure Syndrome Test at DNA Labs UAE
The Bone Marrow Failure Syndrome Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify various conditions that lead to the insufficient production of blood cells by the bone marrow. These conditions can be inherited or acquired, and early detection is crucial for effective management and treatment. The test examines genetic markers, blood cell counts, and bone marrow function to diagnose syndromes such as aplastic anemia, myelodysplastic syndromes, and others.
The test is priced at 7200 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology employed. Conducted in the state-of-the-art facilities of DNA Labs UAE, patients can expect accuracy, reliability, and confidentiality in their test results. This diagnostic tool is essential for individuals exhibiting symptoms of bone marrow failure or those with a family history of related conditions, guiding their clinical care with precise, personalized information.
The Cardiac Channelopathy Gene Panel Test is a specialized diagnostic tool designed to detect genetic mutations associated with cardiac channelopathies, a group of disorders that affect the heart's electrical activity and can lead to arrhythmias and sudden cardiac death. This comprehensive test examines multiple genes known to be involved in these conditions, providing crucial information for accurate diagnosis, management, and familial risk assessment.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test leverages advanced sequencing technologies to ensure high sensitivity and specificity. With a cost of 7200 AED, it represents a significant investment in personal health, offering insights that can guide preventive measures, treatment decisions, and inform family members about their potential risks. The results from this test can be pivotal in developing personalized management plans for individuals with or at risk of cardiac channelopathies, ultimately aiming to improve outcomes and reduce the risk of life-threatening cardiac events.
The Cardiomyopathy Gene Panel Test is a comprehensive diagnostic tool offered by DNA Labs UAE, aimed at identifying genetic mutations associated with various forms of cardiomyopathy. This condition, characterized by the abnormal functioning of the heart muscle, can lead to heart failure and other serious cardiovascular diseases. By analyzing a specific set of genes known to be linked to cardiomyopathy, this test provides crucial insights into an individual's genetic predisposition to the condition, enabling early detection, personalized treatment plans, and informed family planning decisions.
Priced at 7200 AED, the test represents a significant investment in personal health and wellness. It is particularly recommended for individuals with a family history of cardiomyopathy or those exhibiting symptoms related to heart muscle disorders. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test ensures high accuracy and reliability, offering patients and healthcare providers a valuable resource in the management and understanding of cardiomyopathy.
The "Common Neurological Neuromuscular Diseases Gene Panel Test" is a sophisticated diagnostic tool designed to identify genetic mutations associated with a range of neurological and neuromuscular disorders. Conducted at DNA Labs UAE, this comprehensive test analyzes multiple genes simultaneously, offering insights into conditions that affect the brain, spinal cord, peripheral nerves, and muscles. These disorders may include, but are not limited to, muscular dystrophies, amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), and various types of neuropathies.
The test is particularly valuable for individuals with symptoms suggestive of neurological or neuromuscular diseases, families with a history of such conditions, or for those seeking a precise diagnosis to guide treatment and management strategies. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then examined using advanced genetic sequencing techniques.
Priced at 7200 AED, the test is an investment in health, offering potential benefits such as early detection, personalized treatment plans, and the opportunity to make informed decisions about family planning. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in genetic testing, ensuring accurate and reliable results. This test represents a crucial step forward in the diagnosis and understanding of complex neurological and neuromuscular diseases, empowering patients and healthcare providers with critical information for managing these challenging conditions.
